Yeung Anthony, Kiss Alex, Gallagher Damien
Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.
Evaluative Clinical Sciences, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Ontario, Canada.
Int J Geriatr Psychiatry. 2020 Aug;35(8):888-896. doi: 10.1002/gps.5309. Epub 2020 Apr 21.
Intensive control of hypertension has been reported to decrease risk of cognitive decline. However, the effect of this in older adults with hypertension and comorbid depression is not well understood. We aim to identify whether intensive control of systolic blood pressure (BP) is associated with reduced risk of Alzheimer's dementia (AD) in a clinical population.
Using data from the National Alzheimer's Coordinating Center, we conducted survival analyses in older adults with normal cognition at baseline and treated hypertension. We also examined those with comorbid depression, to determine if intensive control of systolic BP (≤120 mmHg) was associated with reduced risk of AD.
In all older adults with treated hypertension (n = 4505), 298 (6.6%) developed AD during a median follow-up duration of 4.2 years. In the comorbid depression subgroup (n = 1327), 152 (11.5%) developed AD. Intensive control of systolic BP was not significantly associated with reduced risk of AD in the overall sample (HR 1.13, 95%, 0.79-1.64). However, in the comorbid depression subgroup, intensive control of systolic BP (≤120 mmHg) was associated with increased risk of AD (HR 1.49, 95%, 1.03-2.15) compared to standard control (121-139 mmHg).
In a clinical population of older adults with hypertension and comorbid depression, we found that an intensive systolic BP target of ≤120 mmHg was associated with increased risk of AD. While these findings are preliminary, they suggest that a more cautious approach to hypertension treatment may be warranted in this vulnerable subgroup.
据报道,强化控制高血压可降低认知能力下降的风险。然而,对于患有高血压和合并抑郁症的老年人,其效果尚不清楚。我们旨在确定在临床人群中,强化控制收缩压(BP)是否与降低阿尔茨海默病(AD)风险相关。
利用国家阿尔茨海默病协调中心的数据,我们对基线认知正常且患有高血压的老年人进行了生存分析。我们还对合并抑郁症的患者进行了检查,以确定强化控制收缩压(≤120mmHg)是否与降低AD风险相关。
在所有接受高血压治疗的老年人(n = 4505)中,298人(6.6%)在中位随访期4.2年期间患上了AD。在合并抑郁症亚组(n = 1327)中,152人(11.5%)患上了AD。在总体样本中,强化控制收缩压与降低AD风险无显著相关性(HR 1.13,95%,0.79 - 1.64)。然而,在合并抑郁症亚组中,与标准控制(121 - 139mmHg)相比,强化控制收缩压(≤120mmHg)与AD风险增加相关(HR 1.49,95%,1.03 - 2.15)。
在患有高血压和合并抑郁症的老年临床人群中,我们发现收缩压强化目标≤120mmHg与AD风险增加相关。虽然这些发现是初步的,但它们表明在这个脆弱的亚组中,可能需要采取更谨慎的高血压治疗方法。